Wael A. A. Fadaly, Mohamed T. M. Nemr, Taha H. Zidan, Fatma E. A. Mohamed, Marwa M. Abdelhakeem, Nour N. Abu Jayab, . . . Khaled R. A. Abdellatif. (2023). New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs: Design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study. Taylor & Francis Group.
Chicago Style (17th ed.) CitationWael A. A. Fadaly, Mohamed T. M. Nemr, Taha H. Zidan, Fatma E. A. Mohamed, Marwa M. Abdelhakeem, Nour N. Abu Jayab, Hany A. Omar, and Khaled R. A. Abdellatif. New 1,2,3-triazole/1,2,4-triazole Hybrids Linked to Oxime Moiety as Nitric Oxide Donor Selective COX-2, Aromatase, B-RAFV600E and EGFR Inhibitors Celecoxib Analogs: Design, Synthesis, Anti-inflammatory/anti-proliferative Activities, Apoptosis and Molecular Modeling Study. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationWael A. A. Fadaly, et al. New 1,2,3-triazole/1,2,4-triazole Hybrids Linked to Oxime Moiety as Nitric Oxide Donor Selective COX-2, Aromatase, B-RAFV600E and EGFR Inhibitors Celecoxib Analogs: Design, Synthesis, Anti-inflammatory/anti-proliferative Activities, Apoptosis and Molecular Modeling Study. Taylor & Francis Group, 2023.